Table 2. Structures and in vitro inhibitory potencies of compounds 54–59 against the β5i subunit of human iCP.
| ||
Compound | R | RA (%) at 10 μM or IC50 for β5i (nM) |
54 | 62 ± 3 | |
55 | IC50 = 1830 ± 380 | |
56 | 101 ± 7 | |
57 | 111 ± 16 | |
58 | 99 ± 9 | |
59 | 102 ± 9 |